{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Apixaban  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Apixaban. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Apixaban  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "apixaban",
    "trial_2_text": "Apixaban  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Apixaban Supplement: 60 participants will take Apixaban 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Apixaban. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Apixaban  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2808016240596771,
      "123": 0.1883113831281662,
      "78": 0.17371243238449097,
      "21": 0.1665995717048645,
      "46": 0.14037363231182098,
      "173": 0.13680782914161682,
      "64": 0.1357545107603073,
      "9": 0.13424868881702423,
      "67": 0.12746292352676392,
      "17": 0.12147948145866394,
      "37": 0.11138230562210083,
      "189": 0.11134372651576996,
      "177": 0.10323428362607956,
      "188": 0.10199802368879318,
      "20": 0.10186076164245605,
      "68": 0.09940549731254578,
      "49": 0.09195934981107712,
      "104": 0.08781158179044724,
      "5": 0.08520792424678802,
      "85": 0.08402255177497864,
      "228": 0.08261577039957047,
      "18": 0.07371550798416138,
      "350": 0.07345670461654663,
      "14": 0.07130835950374603,
      "79": 0.07076513767242432,
      "29": 0.06925474852323532,
      "77": 0.06886886805295944,
      "114": 0.06834880262613297,
      "200": 0.06654176861047745,
      "243": 0.06589095294475555,
      "4": 0.06450024992227554,
      "76": 0.06423596292734146,
      "396": 0.062424253672361374,
      "121": 0.06195883825421333,
      "2": 0.06195523589849472,
      "69": 0.06133115291595459,
      "72": 0.060680288821458817,
      "101": 0.060295119881629944,
      "147": 0.060175105929374695,
      "239": 0.059456612914800644,
      "116": 0.05941025912761688,
      "126": 0.05799003317952156,
      "30": 0.057151615619659424,
      "180": 0.057018380612134933,
      "96": 0.05210518464446068,
      "276": 0.051557183265686035,
      "151": 0.05071679502725601,
      "179": 0.04918390139937401,
      "139": 0.04864247143268585,
      "28": 0.048433706164360046,
      "86": 0.04798920452594757,
      "61": 0.04734160751104355,
      "191": 0.04731449484825134,
      "27": 0.04670437052845955,
      "131": 0.04602951556444168,
      "193": 0.04527110233902931,
      "204": 0.04435986280441284,
      "441": 0.04399757459759712,
      "98": 0.043788451701402664,
      "82": 0.04348142072558403,
      "269": 0.04310062155127525,
      "38": 0.04307491332292557,
      "122": 0.042688630521297455,
      "253": 0.04211539030075073,
      "257": 0.0403699167072773,
      "249": 0.0403151661157608,
      "361": 0.03974875062704086,
      "15": 0.038246989250183105,
      "35": 0.03807142749428749,
      "286": 0.03762834146618843,
      "136": 0.037476614117622375,
      "142": 0.03741592541337013,
      "130": 0.03635682165622711,
      "356": 0.0355643667280674,
      "261": 0.035105057060718536,
      "282": 0.0349324606359005,
      "138": 0.03467611223459244,
      "339": 0.03350052610039711,
      "31": 0.03298334777355194,
      "75": 0.0328606553375721,
      "271": 0.03277452290058136,
      "466": 0.03225502744317055,
      "503": 0.03192126750946045,
      "36": 0.031759485602378845,
      "33": 0.0316738486289978,
      "288": 0.031468022614717484,
      "164": 0.03142325580120087,
      "454": 0.0313657708466053,
      "199": 0.031160740181803703,
      "268": 0.030743256211280823,
      "211": 0.030497677624225616,
      "194": 0.030475687235593796,
      "11": 0.030299479141831398,
      "535": 0.030165165662765503,
      "263": 0.030107654631137848,
      "618": 0.029722418636083603,
      "382": 0.0296485535800457,
      "186": 0.02946281060576439,
      "254": 0.02848702110350132,
      "422": 0.028284952044487
    },
    "trial_2_ae": {
      "87": 0.2808016240596771,
      "123": 0.1883113831281662,
      "78": 0.17371243238449097,
      "21": 0.1665995717048645,
      "46": 0.14037363231182098,
      "173": 0.13680782914161682,
      "64": 0.1357545107603073,
      "9": 0.13424868881702423,
      "67": 0.12746292352676392,
      "17": 0.12147948145866394,
      "37": 0.11138230562210083,
      "189": 0.11134372651576996,
      "177": 0.10323428362607956,
      "188": 0.10199802368879318,
      "20": 0.10186076164245605,
      "68": 0.09940549731254578,
      "49": 0.09195934981107712,
      "104": 0.08781158179044724,
      "5": 0.08520792424678802,
      "85": 0.08402255177497864,
      "228": 0.08261577039957047,
      "18": 0.07371550798416138,
      "350": 0.07345670461654663,
      "14": 0.07130835950374603,
      "79": 0.07076513767242432,
      "29": 0.06925474852323532,
      "77": 0.06886886805295944,
      "114": 0.06834880262613297,
      "200": 0.06654176861047745,
      "243": 0.06589095294475555,
      "4": 0.06450024992227554,
      "76": 0.06423596292734146,
      "396": 0.062424253672361374,
      "121": 0.06195883825421333,
      "2": 0.06195523589849472,
      "69": 0.06133115291595459,
      "72": 0.060680288821458817,
      "101": 0.060295119881629944,
      "147": 0.060175105929374695,
      "239": 0.059456612914800644,
      "116": 0.05941025912761688,
      "126": 0.05799003317952156,
      "30": 0.057151615619659424,
      "180": 0.057018380612134933,
      "96": 0.05210518464446068,
      "276": 0.051557183265686035,
      "151": 0.05071679502725601,
      "179": 0.04918390139937401,
      "139": 0.04864247143268585,
      "28": 0.048433706164360046,
      "86": 0.04798920452594757,
      "61": 0.04734160751104355,
      "191": 0.04731449484825134,
      "27": 0.04670437052845955,
      "131": 0.04602951556444168,
      "193": 0.04527110233902931,
      "204": 0.04435986280441284,
      "441": 0.04399757459759712,
      "98": 0.043788451701402664,
      "82": 0.04348142072558403,
      "269": 0.04310062155127525,
      "38": 0.04307491332292557,
      "122": 0.042688630521297455,
      "253": 0.04211539030075073,
      "257": 0.0403699167072773,
      "249": 0.0403151661157608,
      "361": 0.03974875062704086,
      "15": 0.038246989250183105,
      "35": 0.03807142749428749,
      "286": 0.03762834146618843,
      "136": 0.037476614117622375,
      "142": 0.03741592541337013,
      "130": 0.03635682165622711,
      "356": 0.0355643667280674,
      "261": 0.035105057060718536,
      "282": 0.0349324606359005,
      "138": 0.03467611223459244,
      "339": 0.03350052610039711,
      "31": 0.03298334777355194,
      "75": 0.0328606553375721,
      "271": 0.03277452290058136,
      "466": 0.03225502744317055,
      "503": 0.03192126750946045,
      "36": 0.031759485602378845,
      "33": 0.0316738486289978,
      "288": 0.031468022614717484,
      "164": 0.03142325580120087,
      "454": 0.0313657708466053,
      "199": 0.031160740181803703,
      "268": 0.030743256211280823,
      "211": 0.030497677624225616,
      "194": 0.030475687235593796,
      "11": 0.030299479141831398,
      "535": 0.030165165662765503,
      "263": 0.030107654631137848,
      "618": 0.029722418636083603,
      "382": 0.0296485535800457,
      "186": 0.02946281060576439,
      "254": 0.02848702110350132,
      "422": 0.028284952044487
    }
  },
  "safety": {
    "trial_1_safety": 0.2926770746707916,
    "trial_2_safety": 0.2926770746707916
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4803227484226227
  }
}